Price T Rowe Associates Inc Harpoon Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.78 - $5.02 $50,244 - $141,699	-28,227 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.54 - $8.08 $15,930 - $36,360	4,500 Added 18.97%	28,227 $140,000
Q4 2021 Feb 14, 2022	BUY	$5.69 - $7.83 $50,641 - $69,687	8,900 Added 60.03%	23,727 $179,000
Q2 2021 Aug 16, 2021	BUY	$13.81 - $23.25 $10,316 - $17,367	747 Added 5.31%	14,827 $206,000
Q1 2021 May 17, 2021	BUY	$17.65 - $24.16 $2,100 - $2,875	119 Added 0.85%	14,080 $295,000
Q4 2020 Feb 16, 2021	BUY	$12.83 - $17.84 $179,119 - $249,064	13,961 New	13,961 $232,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.